SecProbe.io

<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

<PAGE>

                                      Draft

April 11, 2005

Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, DC 20549

Attn:  Ms. Angela Crane, Reviewing Accountant

Re:    Becton Dickinson & Company (the "Company")
       Form 10-K for the fiscal year ended September 30, 2004
       Filed December 13, 2004
       Quarterly Report on Form 10-Q for the quarter ended December 31, 2004
       Form 8-K dated January 26, 2005
       File No. 001-04802

Ladies and Gentlemen:

This letter is in response to your comments on the above filings contained in
your letter of March 23, 2005. This response letter has been reviewed with the
Company's independent registered public accounting firm, Ernst & Young LLP, in
advance of mailing to you. In connection with this response, the Company
acknowledges that:

     o    The Company is responsible for the adequacy and accuracy of the
          disclosure in its filings;

     o    Staff comments or changes to disclosures in response to Staff comments
          in the filings reviewed by the Staff do not foreclose the Securities
          and Exchange Commission (the "Commission") from taking any action with
          respect to the filing; and

     o    The Company may not assert Staff comments as a defense in any
          proceeding initiated by the Commission or any person under the Federal
          securities laws of the United States.

Form 10-K for the Fiscal Year Ended September 30, 2004

Item 9A Controls and Procedures - Page 12

Response to Comment 1:

We will provide clarification with respect to the conclusions reached by our
Chief Executive Officer and Chief Financial Officer with respect to the
effectiveness of our

                                       1

<PAGE>

disclosure controls and procedures, by revising our disclosure in future
filings. For example, the disclosure from the subject Form 10-K would appear as
follows:

"An evaluation was carried out by BD's management, with the participation of our
Chief Executive Officer and Chief Financial Officer, of the effectiveness of the
design and operation of BD's disclosure controls and procedures (as defined in
Rule 13a-15(e) under the Securities Exchange Act of 1934) as of [end of period].
Based upon that evaluation, the Chief Executive Officer and Chief Financial
Officer concluded that the design and operation of these disclosure controls and
procedures were, as of the end of the period covered by this report, adequate
and effective to ensure that material information relating to BD and its
consolidated subsidiaries would be made known to them by others within
these entities."

Exhibit 13
Financial Review - Page 24
Results of Continuing Operations - Page 25

Response to Comment 2:

We disclosed on page 24 of the Financial Review that revenue growth in 2004 of
11% included 5% relating to the estimated favorable impact of foreign currency
translation and the remainder resulted primarily from volume increases in all
segments. We did not specifically disclose the impact relating to changes in
sales prices, as it represented only about 1% of the total growth of 11%. We
will expand our disclosure in future Form 10-K filings to quantify the impact of
changes in sales prices on revenue fluctuations.

Response to Comment 3:

We will expand our disclosures in future filings to separately quantify each
significant factor resulting in fluctuations in segment operating income. We
will apply this approach where practicable throughout the MD&A.

Financial Statements - Page 37
Note 2. Accounting Changes - Page 44
Inventories - Page 45

Response to Comment 4:

We are hereby informing the Staff supplementally that the retroactive
restatement for the change to the FIFO costing method had no impact to the
Consolidated Statements of Income during the three years presented (2003, 2002
and 2001), because in the three years presented, there was no significant change
in LIFO reserves as a result of the lack of inflation, such that the cost of
products sold under the LIFO method approximated the cost of products sold under
the FIFO method.

                                       2

<PAGE>

Note 16. Segment Data - Page 59

Response to Comment 5:

We are hereby informing the Staff supplementally, that there was no individual
foreign country whose revenues for the Company's 2004 fiscal year exceeded 7% of
the Company's consolidated revenues or whose long-lived assets as of September
30, 2004 exceeded 7% of the Company's consolidated long-lived assets as of such
date. In future Form 10-K filings, we will include disclosures on revenues or
long-lived assets relating to individual foreign countries that exceed a 10%
threshold, to the extent circumstances warrant.

Form 10-Q for the Quarterly Period Ended December 31, 2004

Management's Discussion and Analysis of Financial Condition and Results of
Operations - Page 16
Use of Non-GAAP Financial Measures - Page 22

Response to Comments 6 and 7:

We will revise our disclosures in future filings to disclose and quantify the
impact the transactions cited in these comments had on the Company's U.S. GAAP
results, including the impact of foreign currency translation included in
revenues and revenue growth, and will otherwise comply with Item 10(e) of
Regulation S-K.

On page 22 of the MD&A discussion, we describe the presentation of certain
non-GAAP measures in discussing BD's financial performance, including: (i)
revenues at constant foreign exchange rates, (ii) earnings per share and other
financial measures after excluding the impact of significant charges, unusual or
non-recurring items, (iii) share-based compensation expense for the period and
(iv) the effects of changes in tax laws and regulations and events that cause
the tax rate for the period being presented to vary from the company's expected
effective tax rate for the full fiscal year. This qualitative discussion is
intended to capture all of the different situations when we may use non-GAAP
financial measures in a discussion of our financial performance, and provide
explanations as to why our management believes that presentation of the non-GAAP
financial measure provides useful information to investors regarding our
financial condition and results of operations.

The Staff in its comments indicates concerns regarding this presentation of
non-GAAP information and adjustments for items characterized as unusual or
nonrecurring. Item

                                       3

<PAGE>

10(e) specifically prohibits adjustments of a non-GAAP performance measure to
eliminate or smooth items identified as non-recurring, infrequent or unusual,
when the nature of the charge or gain is such that it is reasonably likely to
recur within two years or there was a similar charge or gain within the prior
two years.

We do not believe that we have presented non-GAAP financial measures in the MD&A
that are contrary to this prohibition. Although we include on page 22 a
statement that we at times will present earnings per share excluding the impact
of significant charges and unusual or non-recurring items, the Form 10-Q does
not include any non-GAAP financial measure that is adjusted for an item
identified by the Company as either unusual or nonrecurring. Our disclosure on
page 22 was not intended to imply that any of the items excluded from the
non-GAAP financial measures actually presented were "unusual or non-recurring",
and to avoid future confusion, we will eliminate this reference to unusual or
non-recurring items in our discussion on the presentation of non-GAAP financial
measures in future filings, unless it is pertinent to our use of a non-GAAP
financial measure in a filing.

Form 8-K dated January 26, 2005

Response to Comment 8:

In future filings, we will revise our presentation to omit the pro forma
terminology when referring to non-GAAP information.

Response to Comment 9:

In our Form 8-K dated January 26, 2005, we provide certain non-GAAP measures
that are related to share-based compensation expense and certain tax matters
discussed in our earnings release. For example, with respect to share-based
compensation expense, we note that we are an early adopter of Statement of
Financial Accounting Standards No. 123 (revised 2004), Share-Based Payment
("Statement 123(R)"). We began recording share-based compensation expense under
Statement 123(R) beginning in the first quarter of our 2005 fiscal year, which
is the subject of this Form 8-K. As disclosed, we selected the modified
prospective method, as prescribed by Statement 123(R), and therefore, prior
periods were not restated. Given that companies are not yet required to comply
with Statement 123(R) until their first reporting period after June 15, 2005 and
the level of confusion already expressed about the application of Statement
123(R) in the marketplace, we believe that it is useful to provide investors
with non-GAAP measures related to share-based compensation expense, particularly
to facilitate their ability to compare our results with prior periods in which
this expense was not recognized. We note that the Staff indicated in the Staff
Accounting Bulletin No. 107 that a measure excluding share-based compensation
expense that is used by management to evaluate performance may be relevant
disclosure for investors. We do not intend to use non-GAAP financial measures
adjusted for share-based compensation expense after the

                                       4

<PAGE>

completion of our 2005 fiscal year, since by that point investors will no longer
need the information to assist them with comparing our operating performance
from period to period.

The Staff indicated in their comments that we should provide a specific and
detailed explanation of why each non-GAAP measure is useful to investors and how
each of these measures is used by management. We respectfully submit that as the
explanations for each non-GAAP financial measure, adjusted for either
share-based compensation expense or these tax items, is exactly the same, a
separate discussion related to each measure would be unnecessarily repetitive.
However, to the extent these types of non-GAAP financial measures are disclosed
in future filings, we will revise the applicable disclosures under the heading
Use of Non-GAAP Financial Measures as follows:

     o   We present certain financial measures after excluding the impact of
         share-based compensation expense for the period, to the extent the
         period is being compared to a prior period where such expense was not
         recognized. These financial measures include adjustments for the
         impact of share-based compensation expense on earnings per share, cost
         of good sold, gross profit, selling and administrative expense,
         research and development expense, operating income and income from
         continuing operations (both alone and as a percentage of revenues),
         and income taxes. We believe that providing such adjusted results,
         excluding these expenses, allows investors to better understand BD's
         comparative operating performance for the period presented.

     o   We present earnings per share, income taxes, effective tax rate, and
         income from continuing operations (both alone and as a percentage of
         revenues) after excluding the effects of changes in tax laws and
         regulations (including without limitation, rate changes) and other
         events that cause the tax rate for the period being presented to vary
         from the Company's expected effective tax rate for the full fiscal
         year. These items result in fluctuations in our earnings per share and
         other financial measures from period to period that are unrelated to
         BD's underlying operating performance. Accordingly, we believe that
         providing the impact of such effects allows investors to better
         understand BD's comparative operating performance for the period
         presented.

In addition, in future filings we intend to expand the current discussion of the
use of non-GAAP financial measures to include the following:

         BD's management uses each of these non-GAAP financial measures in its
         own evaluation of BD's performance, particularly when comparing
         performance to past periods. Management also uses the non-GAAP results
         for budget planning purposes on a quarterly and annual basis.

         Non-GAAP results should not be considered in isolation and are not in
         accordance with, or a substitute for, GAAP results. Our non-GAAP
         results may differ from similar measures used by other companies, even
         if

                                       5

<PAGE>

         similar terms are used to identify such measures. Although BD's
         management believes non-GAAP results are useful in evaluating the
         performance of its business, its reliance on these measures is limited
         since items excluded from such measures may have a material impact on
         the Company's net income, net income per share, or cash flows
         calculated in accordance with GAAP. Therefore, management typically
         uses non-GAAP results in conjunction with GAAP results to address
         these limitations. Investors should also consider these limitations
         when evaluating BD's results.

         BD provides non-GAAP measures to investors on a supplemental basis, as
         they provide additional insight into BD's financial results. Management
         believes the non-GAAP results provide a reasonable measure of BD's
         underlying performance before the effects of items that are considered
         by management to be outside of BD's underlying operational results or
         that affect period to period comparability.

If you would like to discuss these responses, please call either Mr. William
Tozzi at (201) 847-7076 or myself at (201) 847-7322.

Very truly yours,

John R. Considine
Executive Vice President and
Chief Financial Officer

cc:      Brian Cascio, Accounting Branch Chief, Division of Corporation Finance
         Lynn Dicker, Staff Accountant, Division of Corporation Finance
         Kathryn J. Garbarini, Director of Financial Reporting and Policy
         Edward J. Ludwig, Chairman, President and Chief Executive Officer
         Brenda McAuliffe (Partner of Ernst & Young, LLP)
         Bud McDonald (Partner of Ernst & Young, LLP)
         Jeffrey Small (Partner of Davis, Polk & Wardwell)
         Jeffery S. Sherman, Vice President and General Counsel
         William A. Tozzi, Vice President and Controller
         Members of the Audit Committee

                                      6

</TEXT>
</DOCUMENT>